Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Curr Opin Rheumatol. 2020 Jul;32(4):371–379. doi: 10.1097/BOR.0000000000000713

Figure 3.

Figure 3.

Reactive therapeutic drug monitoring-based algorithm for optimizing infliximab therapy in inflammatory bowel disease.

ATI: antibodies to infliximab; TDM: therapeutic drug monitoring.